据BioworldToday报道，两种重组滤泡刺激激素产品获美国FDA批准上市。这两种产品适用于治疗不育症，并且能皮下自注给药。Organon公司的β促滤泡素（follitropinbeta,商品名Follistim）将在一个月内上市。作为基础排卵治疗，最常规的疗程需15～20瓶Follistim，直至出现排卵；然 According to BioworldToday reports, two recombinant follicular stimulating hormone products approved by the US FDA market. These two products are suitable for the treatment of infertility, and can subcutaneous self-injection. Organon’s follitropin beta (Follistim) will be available in a month. As the basis of ovulation treatment, the most common course of treatment required 15 to 20 bottles of Follistim until ovulation;